| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/16/2008 | EP1878439A2 Actinobacillus pleuropneumoniae virulence genes |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1877800A2 Synthetic and standardized prion infectuous material, and uses thereof as an infecting inoculum |
| 01/16/2008 | EP1877547A1 Selecting, culturing and creating lineage committed hematopoietic stem cells |
| 01/16/2008 | EP1877546A1 Directed neural differentiation |
| 01/16/2008 | EP1877545A2 Mammalian expression systems |
| 01/16/2008 | EP1877544A2 Recovery of tissue function following administration of b cells to injured tissue |
| 01/16/2008 | EP1877543A1 Choroid plexus preparation and uses thereof |
| 01/16/2008 | EP1877542A1 A method for producing stem cells or stem cell-like cells from mammalian embryos |
| 01/16/2008 | EP1877541A2 Method of obtaining a population of human haemopoietic stem cells |
| 01/16/2008 | EP1877540A1 Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells |
| 01/16/2008 | EP1877443A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 01/16/2008 | EP1877436A2 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 01/16/2008 | EP1877429A2 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| 01/16/2008 | EP1877417A2 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells |
| 01/16/2008 | EP1877198A1 A method for producing a nitrogen functionalised surface |
| 01/16/2008 | EP1877088A2 Vaccine against pandemic strains of influenza viruses |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1877030A2 Duffy antigen receptor for chemokines and use thereof |
| 01/16/2008 | EP1699916B1 Process for recycling solid supports for cultivation of anchorage-dependent cells |
| 01/16/2008 | EP1513877B1 Marker for stem cells and its use |
| 01/16/2008 | EP1351979B1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1325142B1 Virus-based amplification vectors for plants |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1287118B1 Method for producing a recipient-specific tissue transplant or tissue implant |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1210410B1 Metal binding compounds and their use in cell culture medium compositions |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1100534B1 Equine system for non-surgical artificial insemination |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107353A Mutant glucose dehydrogenase |
| 01/16/2008 | CN101105492A Monoclonal antibody and enzyme-linked immunoassay method and reagent kit for detecting tylosin and tilmicosin residue |
| 01/16/2008 | CN101104845A Use of protocatechuic acid in accelerating nerve stem cell multiplication in vitro and inducement differentiation |
| 01/16/2008 | CN101103702A Excised reproduction method for mountain ash |
| 01/16/2008 | CN101103701A Curcuma wenyujin detoxicating and quick reproduction method |
| 01/16/2008 | CN101103700A Tissue quick reproduction method of radix tetrastigmae |
| 01/16/2008 | CN100362106C Glyt1 conditional knock-out mice |
| 01/16/2008 | CN100362099C Drug resistant cell strain of human oophoroma and culturing method |
| 01/16/2008 | CN100362098C Non-serum culture medium for multiple animal cell large-scale culture |
| 01/16/2008 | CN100362097C High efficiency fast culturing method of tobacco protoplast |
| 01/16/2008 | CN100362096C Method for obtaining amphihaploid plant of pumpkin ovule and its special culture medium |
| 01/16/2008 | CN100362095C Composition and methods useful for HCV infection |
| 01/16/2008 | CN100362012C Method for synthesizing secoiridoid glycosides compound |
| 01/16/2008 | CN100361569C Method for preparing plant haploid embryo and haploid plant |
| 01/15/2008 | US7319183 Inbred corn line PHEGV |
| 01/15/2008 | US7319182 Plants and seeds of corn variety LH360 |
| 01/15/2008 | US7319144 Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay |
| 01/15/2008 | US7319143 Genetically-engineered MHC molecules |
| 01/15/2008 | US7319141 Stem cell growth factor-like polypeptides |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7319036 Dominant negative alleles of human mismatch repair genes introduced into cells and transgenic animals |
| 01/15/2008 | US7319035 Biological scaffolding material |
| 01/15/2008 | US7319033 Transcritpional control; prostate glands; anticancer agents |
| 01/15/2008 | US7319020 Method for carrying out the controlled post-harvest production of proteins in host organisms |
| 01/15/2008 | US7319019 Biodrug has glial cell mitogenic activity; induce central glial proliferation to induce myelination and treat multiple sclerosis |
| 01/15/2008 | US7319013 Preparing a probe and screening genomic library or cDNA library of the species in question; or conducting computer search for analogous sequences in an electronic data base; expression cassettes; plant growth regulators |
| 01/15/2008 | US7318998 Rendering tissues acellular and limiting mineralization and/or immunoreactivity after grafting; prosthetics; treating cardiac valve disorders |
| 01/15/2008 | US7318923 Humanized anti-βantibodies |
| 01/15/2008 | US7318922 Anti-PRO5337 antibodies |
| 01/15/2008 | US7318919 Adenovirus vectors for gene therapy |
| 01/15/2008 | CA2495219C Stress tolerance and delayed senescence in plants |
| 01/15/2008 | CA2309556C Detection systems for registering protein interactions and functional relationships |
| 01/15/2008 | CA2309131C Plant-optimized genes encoding pesticidal toxins |
| 01/15/2008 | CA2307960C Dna encoding for plant digalactosyldiacylglycerol galactosyltransferase and methods of use |
| 01/15/2008 | CA2296769C Modified dorsal tissue affecting factor and compositions |
| 01/15/2008 | CA2290768C Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
| 01/15/2008 | CA2284255C Prevention of bt resistance development |
| 01/15/2008 | CA2268014C Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 01/15/2008 | CA2260765C Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/15/2008 | CA2209659C Insecticidal protein toxins from photorhabdus |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/15/2008 | CA2195303C Method for selecting high-expressing host cells |
| 01/15/2008 | CA2093427C Molecular clones of hiv-1 and uses thereof |
| 01/15/2008 | CA2054762C Production of enzymes in seeds and their use |
| 01/13/2008 | CA2596599A1 Epidermis equivalent capable of pigmenting obtained from matrix cells, preparation process and use |
| 01/10/2008 | WO2008006104A2 Enhanced oxygen cell culture platforms |
| 01/10/2008 | WO2008005210A2 Improved yield and stress tolerance in transgenic plants |
| 01/10/2008 | WO2008005019A1 Compositions and methods for the treatment of muscle wasting |
| 01/10/2008 | WO2008005002A1 Compositions and methods for the treatment of muscle wasting |
| 01/10/2008 | WO2008004990A2 Method for stem cell culture and cells derived therefrom |
| 01/10/2008 | WO2008004819A1 Method for isolation of a hair follicle stem cell and a composition for hair reproduction |
| 01/10/2008 | WO2008004752A1 Method for preparing mesenchymal stem cells by ultrasonic treatment |
| 01/10/2008 | WO2008004674A1 PRO-CLOTTING ENZYME, AND METHOD FOR DETECTION OF ENDOTOXIN OR (1→3)-β-D-GLUCAN USING THE SAME |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008004260A2 Bio-membrane for tissue regeneration |
| 01/10/2008 | WO2008003925A2 Complement protein |
| 01/10/2008 | WO2008003691A2 Oocyte maturation method |
| 01/10/2008 | WO2008003489A1 Cellular pyrogenic test using toll-like receptor |
| 01/10/2008 | WO2007125088A3 Kidney-derived stem cell population, identification and therapeutic use |
| 01/10/2008 | WO2007117262A3 Culture of non-embryonic cells at high cell density |